Paris, France, 3rd January 2018 – Pharmaleads, an emerging pharmaceutical company developing innovative non-opiate and non-addictive products for the management of acute and chronic severe pain, today announces its participation at the upcoming 10th Annual Biotech Showcase™ Conference to be held in San Francisco (CA, United States) on January 8 – 10, 2018. Thierry Bourbié, CEO of Pharmaleads, will provide a corporate update and pipeline overview at the conference.
- Date: Monday 8th January 2018
- Time: 2:00 pm PT
- Duration: 15 minutes
- Location: Room D – Ballroom at the Hilton San Francisco Union Square
Thierry Bourbié, CEO of Pharmaleads, said, “We are delighted to be presenting at this highly respected and well-attended investor conference. We believe our presentation at Biotech Showcase will provide investors with an exciting overview of Pharmaleads cutting-edge pipeline of Dual ENKephalinase Inhibitors for the management of acute and chronic severe pain. Our compounds have the potential to completely change the game in the opioid crisis by providing safe and non-addictive pain relief to patients suffering from severe pain of all types.”